THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

Dades bibliogràfiques
Autors principals:	Maddison, P, Titulaer, M, Verschuuren, J, Gozzard, P, Lang, B, Willcox, N, Vincent, A, Irani, SR, Chapman, C
Format:	Conference item
Publicat:	2012

Ítems similars

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders
per: Maddison, P, et al.
Publicat: (2018)

Antibodies associated with paraneoplastic neurological disorders.
per: Vincent, A
Publicat: (2005)

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies
per: Cristina Arnaldos-Pérez, et al.
Publicat: (2023-05-01)

Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
per: Maddison, P, et al.
Publicat: (2008)

Paraneoplastic neurological syndromes: a practical approach to diagnosis and management
per: Binks, S, et al.
Publicat: (2021)

ANTI-HU PARANEOPLASTIC SENSORY NEURONOPATHY WITH UNDERLYING SQUAMOUS CELL CARCINOMA OF THE LUNG
per: Gozzard, P, et al.
Publicat: (2010)

Recommended diagnostic criteria for paraneoplastic neurological syndromes.
per: Graus, F, et al.
Publicat: (2004)

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.
per: Graus, F, et al.
Publicat: (2005)

Review: Progress in the management of paraneoplastic neurological disorders
per: Hamid Sadeghian, et al.
Publicat: (2010-01-01)

Paraneoplastic neurological syndromes. State of the art
per: Giometto, B, et al.
Publicat: (2006)

Paraneoplastic neurological syndromes
per: Antoine Jean-Christophe, et al.
Publicat: (2007-05-01)

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations
per: Raquel Ruiz-García, et al.
Publicat: (2019-04-01)

N-methyl-d-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
per: Irani, SR, et al.
Publicat: (2010)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
per: Irani, SR, et al.
Publicat: (2010)

Diagnosis of paraneoplastic neurological syndromes
per: Camilo E Fadul MD
Publicat: (2007-07-01)

Diagnosis of paraneoplastic neurological syndromes
per: Camilo E Fadul MD
Publicat: (2007-07-01)

PDE10A antibodies in autoimmune encephalitis: a possible marker of cancer immunotherapy?
per: Titulaer, MJ, et al.
Publicat: (2019)

Antiganglioside antibodies and paraneoplastic neuromuscular junction disorder?
per: Noushin Jazebi, et al.
Publicat: (2020-12-01)

EARLY AND CONTINUED TREATMENT OF N-METHYL D-ASPARTATE RECEPTOR-ANTIBODY ENCEPHALITIS OPTIMISES OUTCOME OF A PREDOMINANTLY NON-PARANEOPLASTIC DISEASE
per: Irani, SR, et al.
Publicat: (2009)

An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes
per: Sai Wang, et al.
Publicat: (2023-01-01)

Anti-Ma2-antibody-associated encephalitis: An atypical paraneoplastic neurologic syndrome
per: Bogna Targonska, et al.
Publicat: (2018-05-01)

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
per: Paul Gozzard, et al.
Publicat: (2015-01-01)

Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
per: Daniel Chiu, et al.
Publicat: (2023-07-01)

Neurological manifestation of cancer – paraneoplastic syndromes
per: Szklener Katarzyna, et al.
Publicat: (2021-06-01)

Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome
per: Tschernatsch, M, et al.
Publicat: (2009)

Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies
per: Jonas Feldheim, et al.
Publicat: (2021-05-01)

Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study
per: Yi Guo, et al.
Publicat: (2021-11-01)

Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
per: Sonja Kosek, et al.
Publicat: (2024-05-01)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
per: Irani, S, et al.
Publicat: (2010)

Autoimmune and paraneoplastic seizures
per: Wagner, B, et al.
Publicat: (2024)

Paraneoplastic neurologic syndrome: A practical approach
per: Sudheeran Kannoth
Publicat: (2012-01-01)

Ovarian Teratoma-Related Paraneoplastic Neurological Syndromes
per: Jingfang Lin, et al.
Publicat: (2022-05-01)

Paraneoplastic neurological syndromes: clinical presentations and management
per: Michelle F. Devine, et al.
Publicat: (2021-01-01)

Predicting disability and mortality in CV2/CRMP5‐IgG associated paraneoplastic neurologic disorders
per: Sanem P. Uysal, et al.
Publicat: (2024-03-01)

A case of paraneoplastic neurological syndrome expressing dual antineuronal antibodies: Anti-hu and recoverin
per: Ho-Sung Ryu, et al.
Publicat: (2020-01-01)

P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.
per: Graus, F, et al.
Publicat: (2002)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
per: Becker, E, et al.
Publicat: (2012)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
per: Becker, E, et al.
Publicat: (2012)

Thymoma and paraneoplastic myasthenia gravis.
per: Marx, A, et al.
Publicat: (2010)

Clinical characteristics and immunotherapy response in paraneoplastic neurologic syndrome patients with increased number of high-risk antibodies
per: Gong Wang, et al.
Publicat: (2025-01-01)